Home / Germany / Outlook Therapeutics Inc

Outlook Therapeutics Inc

US69012T3059 Short position disclosed on June 28, 2024.

0.59% of the capital sold short

1 disclosing funds

1 disclosures on record

Open positions

The funds disclosing a short position that is still open.
Fund	% of capital	Since
Bronte Capital Management Pty Ltd	0.59%	June 28, 2024

1 disclosures on record for this share.
Date	Fund	% of capital	End of publication
June 28, 2024	Bronte Capital Management Pty Ltd	0.59%	still open